SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bank of New York Mellon Corp – ‘10-K’ for 12/31/18

On:  Wednesday, 2/27/19, at 6:54am ET   ·   For:  12/31/18   ·   Accession #:  1390777-19-50   ·   File #:  1-35651

Previous ‘10-K’:  ‘10-K’ on 2/28/18 for 12/31/17   ·   Next:  ‘10-K’ on 2/27/20 for 12/31/19   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/27/19  Bank of New York Mellon Corp      10-K       12/31/18  177:42M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    267K 
 2: EX-13.1     All Portions of 2018 Annual Report to Shareholders  HTML   3.43M 
 3: EX-21.1     Primary Subsidiaries of the Company                 HTML     61K 
 4: EX-23.1     Consent of Kpmg LLP                                 HTML     52K 
 5: EX-24.1     Power of Attorney                                   HTML     55K 
 6: EX-31.1     Section 302 CEO Certification                       HTML     54K 
 7: EX-31.2     Section 302 CFO Certification                       HTML     54K 
 8: EX-32.1     Section 906 CEO Certification                       HTML     48K 
 9: EX-32.2     Section 906 CFO Certification                       HTML     48K 
16: R1          Document and Entity Information                     HTML     82K 
17: R2          Consolidated Income Statement                       HTML    197K 
18: R3          Consolidated Income Statement (Parenthetical)       HTML     50K 
19: R4          Consolidated Comprehensive Income Statement         HTML    111K 
20: R5          Consolidated Balance Sheet                          HTML    192K 
21: R6          Consolidated Balance Sheet (Parenthetical)          HTML     77K 
22: R7          Consolidated Statement of Cash Flows                HTML    211K 
23: R8          Consolidated Statement of Changes in Equity         HTML    137K 
24: R9          Consolidated Statement of Changes in Equity         HTML     49K 
                (Parenthetical)                                                  
25: R10         Summary of significant accounting and reporting     HTML    149K 
                policies                                                         
26: R11         Accounting changes and new accounting guidance      HTML     90K 
27: R12         Acquisitions and dispositions                       HTML     55K 
28: R13         Securities                                          HTML    581K 
29: R14         Loans and asset quality                             HTML    503K 
30: R15         Goodwill and intangible assets                      HTML    141K 
31: R16         Other assets                                        HTML    101K 
32: R17         Deposits                                            HTML     52K 
33: R18         Contract revenue                                    HTML    102K 
34: R19         Net interest revenue                                HTML     89K 
35: R20         Income taxes                                        HTML    151K 
36: R21         Long-term debt                                      HTML     66K 
37: R22         Variable interest entities and securitization       HTML    110K 
38: R23         Shareholders' equity                                HTML    208K 
39: R24         Other comprehensive income (Loss)                   HTML    210K 
40: R25         Stock-based compensation                            HTML    108K 
41: R26         Employee benefit plans                              HTML    566K 
42: R27         Company financial information (Parent Corporation)  HTML    177K 
43: R28         Fair value measurement                              HTML    648K 
44: R29         Fair value option                                   HTML     79K 
45: R30         Commitments and contingent liabilities              HTML    134K 
46: R31         Derivative instruments                              HTML    441K 
47: R32         Lines of business                                   HTML    191K 
48: R33         International operations                            HTML    113K 
49: R34         Supplemental information to the Consolidated        HTML     67K 
                Statement of Cash Flows                                          
50: R35         Summary of significant accounting and reporting     HTML    319K 
                policies (Policies)                                              
51: R36         Summary of significant accounting and reporting     HTML     54K 
                policies (Tables)                                                
52: R37         Accounting changes and new accounting guidance      HTML     67K 
                (Tables)                                                         
53: R38         Securities (Tables)                                 HTML    576K 
54: R39         Loans and asset quality (Tables)                    HTML    503K 
55: R40         Goodwill and intangible assets (Tables)             HTML    143K 
56: R41         Other assets (Tables)                               HTML     97K 
57: R42         Contract revenue (Tables)                           HTML     83K 
58: R43         Net interest revenue (Tables)                       HTML     88K 
59: R44         Income taxes (Tables)                               HTML    152K 
60: R45         Long-term debt (Tables)                             HTML     68K 
61: R46         Variable interest entities and securitization       HTML    113K 
                (Tables)                                                         
62: R47         Shareholders' equity (Tables)                       HTML    199K 
63: R48         Other comprehensive income (Loss) (Tables)          HTML    209K 
64: R49         Stock-based compensation (Tables)                   HTML     97K 
65: R50         Employee benefit plans (Tables)                     HTML    556K 
66: R51         Company financial information (Parent Corporation)  HTML    164K 
                (Tables)                                                         
67: R52         Fair value measurement (Tables)                     HTML    638K 
68: R53         Fair value option (Tables)                          HTML     74K 
69: R54         Commitments and contingent liabilities (Tables)     HTML     97K 
70: R55         Derivative instruments (Tables)                     HTML    436K 
71: R56         Lines of business (Tables)                          HTML    180K 
72: R57         International operations (Tables)                   HTML    112K 
73: R58         Supplemental information to the Consolidated        HTML     66K 
                Statement of Cash Flows (Tables)                                 
74: R59         Summary of significant accounting and reporting     HTML     84K 
                policies - Narrative (Details)                                   
75: R60         Summary of significant accounting and reporting     HTML     56K 
                policies - Equity Method Investments (Details)                   
76: R61         Accounting changes and new accounting guidance -    HTML    104K 
                Narrative (Details)                                              
77: R62         Accounting changes and new accounting guidance -    HTML     75K 
                Cumulative Effect of Adoption of New Guidance                    
                (Details)                                                        
78: R63         Acquisitions and dispositions (Details)             HTML     83K 
79: R64         Securities - Amortized Cost, Gross Unrealized       HTML    168K 
                Gains and Losses and Fair Value (Details)                        
80: R65         Securities - Net Securities Gains (Losses)          HTML     56K 
                (Details)                                                        
81: R66         Securities - Narrative (Details)                    HTML     54K 
82: R67         Securities - Fair Value of Investments with         HTML    182K 
                Continuous Unrealized Loss Position (Details)                    
83: R68         Securities - Maturity Distribution and Yield of     HTML    167K 
                Investment Securities Portfolio (Details)                        
84: R69         Securities - Debt Securities Credit Losses Roll     HTML     56K 
                Forward Recorded in Earnings (Details)                           
85: R70         Securities - Pre-Tax Net Securities Gains (Losses)  HTML     61K 
                by Type (Details)                                                
86: R71         Securities - Pledged assets (Details)               HTML     75K 
87: R72         Loans and asset quality - Loan Distribution and     HTML     94K 
                Industry Concentrations (Details)                                
88: R73         Loans and asset quality - Loans Additional          HTML     49K 
                Information (Details)                                            
89: R74         Loans and asset quality - Allowance for Credit      HTML    173K 
                Losses Activity (Details)                                        
90: R75         Loans and asset quality - Nonperforming Assets      HTML     61K 
                (Details)                                                        
91: R76         Loans and asset quality - Lost Interest (Details)   HTML     55K 
92: R77         Loans and asset quality - Information about         HTML    105K 
                Impaired Loans (Details)                                         
93: R78         Loans and asset quality - Information about Past    HTML     80K 
                Due Loans (Details)                                              
94: R79         Loans and asset quality - Troubled Debt             HTML     66K 
                Restructuring (Details)                                          
95: R80         Loans and asset quality - Credit Risk Profile by    HTML     73K 
                Grade (Details)                                                  
96: R81         Loans and asset quality - Credit Risk Indicators    HTML     94K 
                Narrative (Details)                                              
97: R82         Goodwill and intangible assets - Goodwill           HTML     63K 
                (Details)                                                        
98: R83         Goodwill and intangible assets - Intangible Assets  HTML     66K 
                by Business Segment (Details)                                    
99: R84         Goodwill and intangible assets - Intangible Assets  HTML     82K 
                by Type (Details)                                                
100: R85         Goodwill and intangible assets - Estimated Annual   HTML     59K  
                Amortization Expense (Details)                                   
101: R86         Goodwill and intangible assets - Narrative          HTML     60K  
                (Details)                                                        
102: R87         Other assets - Components of Other Assets           HTML     86K  
                (Details)                                                        
103: R88         Other assets - Qualified Affordable Housing         HTML     68K  
                Project Investments (Details)                                    
104: R89         Other assets - Seed Capital and Private Equity      HTML     75K  
                Investments (Details)                                            
105: R90         Deposits (Details)                                  HTML     63K  
106: R91         Contract revenue - Disaggregation of Contract       HTML    125K  
                Revenues (Details)                                               
107: R92         Contract revenue - Narrative (Details)              HTML     83K  
108: R93         Net interest revenue (Details)                      HTML    103K  
109: R94         Income taxes - Provision (Benefit) for Income       HTML     78K  
                Taxes (Details)                                                  
110: R95         Income taxes - Narrative (Details)                  HTML     74K  
111: R96         Income taxes - Provisional Tax Expense (Benefit)    HTML     55K  
                (Details)                                                        
112: R97         Income taxes - Components of Income before Taxes    HTML     53K  
                (Details)                                                        
113: R98         Income taxes - Components of Net Deferred Tax       HTML     82K  
                Liability (Details)                                              
114: R99         Income taxes - Reconciliation of Effective Tax      HTML     82K  
                Rate (Details)                                                   
115: R100        Income taxes - Unrecognized Tax Positions           HTML     64K  
                (Details)                                                        
116: R101        Long-term debt - Schedule of Long-term Debt         HTML     66K  
                (Details)                                                        
117: R102        Long-term debt - Narrative (Details)                HTML     61K  
118: R103        Variable interest entities and securitization -     HTML     79K  
                Assets and Liabilities of VIEs (Details)                         
119: R104        Variable interest entities and securitization -     HTML     60K  
                Non-consolidated VIEs (Details)                                  
120: R105        Shareholders' equity - Narrative (Details)          HTML     84K  
121: R106        Shareholders' equity - Preferred Stock Summary      HTML     88K  
                (Details)                                                        
122: R107        Shareholders' equity - Summary of Preferred         HTML     68K  
                Dividends Paid (Details)                                         
123: R108        Shareholders' equity - Regulatory Capital Ratios    HTML     67K  
                (Details)                                                        
124: R109        Shareholders' equity - Components of Transitional   HTML    109K  
                Capital (Details)                                                
125: R110        Shareholders' equity - Amounts of Capital           HTML     59K  
                (Details)                                                        
126: R111        Other comprehensive income (loss) - Components      HTML    132K  
                (Details)                                                        
127: R112        Other comprehensive income (loss) - Changes in      HTML     95K  
                AOCI (Details)                                                   
128: R113        Stock-based compensation - Narrative (Details)      HTML    107K  
129: R114        Stock-based compensation - Summary of Stock Option  HTML     92K  
                Activity (Details)                                               
130: R115        Stock-based compensation - Stock Options            HTML     70K  
                Outstanding (Details)                                            
131: R116        Stock-based compensation - Aggregate Intrinsic      HTML     52K  
                Value of Options (Details)                                       
132: R117        Stock-based compensation - Nonvested Restricted     HTML     73K  
                Stock and Restricted Stock Units Activity                        
                (Details)                                                        
133: R118        Employee benefit plans - Narrative (Details)        HTML    124K  
134: R119        Employee benefit plans - Combined Data for Defined  HTML    147K  
                Benefit Pension and Post Retirement Healthcare                   
                Plans (Details)                                                  
135: R120        Employee benefit plans - Net Periodic Benefit       HTML    105K  
                (Credit) Cost (Details)                                          
136: R121        Employee benefit plans - Changes in Other           HTML     73K  
                Comprehensive Income (Loss) (Details)                            
137: R122        Employee benefit plans - Defined Benefit Plan       HTML     63K  
                Funded Status of Plan (Details)                                  
138: R123        Employee benefit plans - Plans with Obligations in  HTML     68K  
                Excess of Plan Assets (Details)                                  
139: R124        Employee benefit plans - Benefit Payments and       HTML     75K  
                Expected to be Paid (Details)                                    
140: R125        Employee benefit plans - Pension Investment Asset   HTML     73K  
                Allocation (Details)                                             
141: R126        Employee benefit plans - Pension Plan Investment    HTML    171K  
                Assets on Recurring Basis (Details)                              
142: R127        Employee benefit plans - Rollforward of Plan        HTML     62K  
                Investment Assets (Details)                                      
143: R128        Employee benefit plans - Pension Plan Assets        HTML     72K  
                Valued Using Net Asset Value (Details)                           
144: R129        Company financial information (Parent Corporation)  HTML     77K  
                - Narrative (Details)                                            
145: R130        Company financial information (Parent Corporation)  HTML     95K  
                - Income Statement (Details)                                     
146: R131        Company financial information (Parent Corporation)  HTML     95K  
                - Balance Sheet (Details)                                        
147: R132        Company financial information (Parent Corporation)  HTML    142K  
                - Cash Flows (Details)                                           
148: R133        Fair value measurement - Narrative (Details)        HTML     48K  
149: R134        Fair value measurement - Assets and Liabilities on  HTML    365K  
                Recurring Basis (Details)                                        
150: R135        Fair value measurement - Certain Items on           HTML    263K  
                Recurring Basis (Details)                                        
151: R136        Fair value measurement - Assets on Nonrecurring     HTML     66K  
                Basis (Details)                                                  
152: R137        Fair value measurement - Financial Instruments      HTML    120K  
                (Details)                                                        
153: R138        Fair value measurement - Derivatives (Details)      HTML     62K  
154: R139        Fair value option - Assets and Liabilities          HTML     60K  
                (Details)                                                        
155: R140        Fair value option - Narrative (Details)             HTML     50K  
156: R141        Fair value option - Changes in Fair Value of Loans  HTML     56K  
                and Long-term Debt (Details)                                     
157: R142        Commitments and contingent liabilities - Summary    HTML     65K  
                of Off-Balance Sheet Credit Risks, Net of                        
                Participations (Details)                                         
158: R143        Commitments and contingent liabilities - Narrative  HTML    127K  
                (Details)                                                        
159: R144        Commitments and contingent liabilities - Standby    HTML     53K  
                Letters of Credits by Investment Grade (Details)                 
160: R145        Commitments and contingent liabilities -            HTML     87K  
                Significant Industry Concentrations Related to                   
                Credit Exposure (Details)                                        
161: R146        Derivative instruments - Narrative (Details)        HTML    100K  
162: R147        Derivative instruments - Gains (Losses) Related to  HTML     86K  
                Hedging Derivative Portfolio Recognized in the                   
                Income Statement (Details)                                       
163: R148        Derivative instruments - Impact of Hedging          HTML     55K  
                Derivatives Used in Net Investment Hedging                       
                Relationships (Details)                                          
164: R149        Derivative instruments - Hedged Items in Fair       HTML     66K  
                Value Hedging Relationships (Details)                            
165: R150        Derivative instruments - Impact of Derivative       HTML    107K  
                Instruments on the Balance Sheet (Details)                       
166: R151        Derivative instruments - Revenue from Foreign       HTML     57K  
                Exchange and Other Trading (Details)                             
167: R152        Derivative instruments - Contracts Falling under    HTML     61K  
                Early Termination Provisions (Details)                           
168: R153        Derivative instruments - Offsetting (Details)       HTML    247K  
169: R154        Derivative instruments - Secured Borrowings         HTML    105K  
                (Details)                                                        
170: R155        Lines of business - Narrative (Details)             HTML     56K  
171: R156        Lines of business - Contribution of Segments to     HTML    101K  
                Overall Profitability (Details)                                  
172: R157        International operations (Details)                  HTML     84K  
173: R158        Supplemental information to the Consolidated        HTML     68K  
                Statement of Cash Flows (Details)                                
174: R9999       Uncategorized Items - bk-20181231.xml               HTML     49K  
176: XML         IDEA XML File -- Filing Summary                      XML    337K  
175: EXCEL       IDEA Workbook of Financial Reports                  XLSX    297K  
10: EX-101.INS  XBRL Instance -- bk-20181231                         XML  16.59M 
12: EX-101.CAL  XBRL Calculations -- bk-20181231_cal                 XML    751K 
13: EX-101.DEF  XBRL Definitions -- bk-20181231_def                  XML   2.49M 
14: EX-101.LAB  XBRL Labels -- bk-20181231_lab                       XML   4.95M 
15: EX-101.PRE  XBRL Presentations -- bk-20181231_pre                XML   3.28M 
11: EX-101.SCH  XBRL Schema -- bk-20181231                           XSD    506K 
177: ZIP         XBRL Zipped Folder -- 0001390777-19-000050-xbrl      Zip    977K  


‘10-K’   —   Annual Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Item 1
"Business
"Item 1A
"Risk factors
"Item 1B
"Unresolved staff comments
"Item 2
"Properties
"Item 3
"Legal proceedings
"Item 4
"Mine safety disclosures
"Item 5
"Market for registrant's common equity, related stockholder matters and issuer purchases of equity securities
"Item 6
"Selected financial data
"Item 7
"Management's discussion and analysis of financial condition and results of operations
"Item 7A
"Quantitative and qualitative disclosures about market risk
"Item 8
"Financial statements and supplementary data
"Item 9
"Changes in and disagreements with accountants on accounting and financial disclosure
"Item 9A
"Controls and procedures
"Item 9B
"Other information
"Item 10
"Directors, executive officers and corporate governance
"Item 11
"Executive compensation
"Item 12
"Security ownership of certain beneficial owners and management and related stockholder matters
"Item 13
"Certain relationships and related transactions, and director independence
"Item 14
"Principal accounting fees and services
"Item 15
"Exhibits, financial statement schedules
"Item 16
"Form 10-K summary
"Index to exhibits
"Signatures

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 10-K

[ X ] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Fiscal Year Ended December 31, 2018
or
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File No. 001-35651

THE BANK OF NEW YORK MELLON CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
13-2614959
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
240 Greenwich Street
New York, New York 10286
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code -- (212) 495-1784
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
Common Stock, $0.01 par value
New York Stock Exchange
Depositary Shares, each representing 1/4,000th of a share of Series C Noncumulative Perpetual Preferred Stock
New York Stock Exchange
6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (Fully and unconditionally guaranteed by The Bank of New York Mellon Corporation)
New York Stock Exchange
 
 
Securities registered pursuant to Section 12(g) of the Act:
Title of class
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ţ No ¨

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No ţ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ţ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ţ No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ţ

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer    ţ    Accelerated filer ¨
Non-accelerated filer    ¨    Smaller reporting company ¨
Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No ţ

As of June 30, 2018, the aggregate market value of the registrant’s common stock, $0.01 par value per share, held by nonaffiliates of the registrant was $53,885,206,227.

As of January 31, 2019, 954,548,741 shares of the registrant’s common stock, $0.01 par value per share, were outstanding.


DOCUMENTS INCORPORATED BY REFERENCE
Portions of the following documents are incorporated by reference in the following parts of this Form 10-K:
The Bank of New York Mellon Corporation 2019 Proxy Statement-Part III
The Bank of New York Mellon Corporation 2018 Annual Report to Shareholders-Parts I, II and IV
 



Available Information

This Form 10-K filed by The Bank of New York Mellon Corporation (“BNY Mellon” or the “Company”) with the Securities and Exchange Commission (the “SEC”) contains the Exhibits listed on the Index to Exhibits beginning on page 15, including those portions of BNY Mellon’s 2018 Annual Report to Shareholders (the “Annual Report”), which are incorporated herein by reference. The Annual Report and BNY Mellon’s Proxy Statement for its 2019 Annual Meeting (the “Proxy”) will be available on our website at www.bnymellon.com. We also make available on our website, free of charge, the following materials:

All of our SEC filings, including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to these reports as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the SEC pursuant to Section 13(a) of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), and any proxy statement mailed by us in connection with the solicitation of proxies;
Financial statements and footnotes prepared using eXtensible Business Reporting Language (“XBRL”);
Our earnings materials and selected management conference calls and presentations;
Other regulatory disclosures, including: Pillar 3 Disclosures (and Market Risk Disclosure contained therein); Liquidity Coverage Ratio Disclosures; Federal Financial Institutions Examination Council - Consolidated Reports of Condition and Income for a Bank With Domestic and Foreign Offices; Consolidated Financial Statements for Bank Holding Companies; and the Dodd-Frank Act Stress Test Results for BNY Mellon and The Bank of New York Mellon; and
Our Corporate Governance Guidelines, Amended and Restated By-laws, Directors Code of Conduct and the Charters of the Audit, Finance, Corporate Governance, Nominating and Social Responsibility, Human Resources and Compensation, Risk and Technology Committees of our Board of Directors.

The contents of BNY Mellon’s website or any other websites referenced herein are not part of this Form 10-K.
 
Forward-looking Statements

In this Form 10-K, and other public disclosures of BNY Mellon, words such as “estimate,” “forecast,” “project,” “anticipate,” “likely,” “target,” “expect,” “intend,” “continue,” “seek,” “believe,” “plan,” “goal,” “could,” “should,” “would,” “may,” “might,” “will,” “strategy,” “synergies,” “opportunities,” “trends,” “future” and words of similar meaning signify forward-looking statements. Some statements in this document are forward-looking. These include all statements about the usefulness of Non-GAAP measures, the future results of BNY Mellon, our businesses, financial, liquidity and capital condition, results of operations, liquidity, risk and capital management and processes, goals, strategies, outlook, objectives, expectations (including those regarding our performance results, expenses, nonperforming assets, seasonality in our businesses, impacts of currency fluctuations, impacts of trends on our businesses, regulatory, technology, market, economic or accounting developments, legal proceedings and other contingencies), effective tax rate, estimates (including those regarding expenses, losses inherent in our credit portfolios, capital ratios and the tax benefit related to U.S. tax legislation), intentions (including those regarding our capital returns and investment in technology), targets, opportunities, growth and initiatives.

These forward-looking statements, and other forward-looking statements contained in other public disclosures of BNY Mellon (including those incorporated into this Form 10-K), are based on assumptions that involve risks and uncertainties and that are subject to change based on various important factors (some of which are beyond BNY Mellon’s control), including those factors described in the Annual Report under “Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) – Risk Factors.” Actual results may differ materially from those expressed or implied as a result of a number of factors, including those discussed in the “Risk Factors” section of our Annual Report, such as:

a communications or technology disruption or failure that results in a loss of information, delays our ability to access information or impacts our ability to provide services to our clients may materially adversely affect our business, financial condition and results of operations;

BNY Mellon 1



a cybersecurity incident, or a failure to protect our computer systems, networks and information and our clients’ information against cybersecurity threats, could result in the theft, loss, unauthorized access to, disclosure, use or alteration of information, system or network failures, or loss of access to information; any such incident or failure could adversely impact our ability to conduct our businesses, damage our reputation and cause losses;
our business may be materially adversely affected by operational risk;
our risk management framework may not be effective in mitigating risk and reducing the potential for losses;
we are subject to extensive government rulemaking, regulation and supervision; these rules and regulations have, and in the future may, compel us to change how we manage our businesses, which could have a material adverse effect on our business, financial condition and results of operations; in addition, these rules and regulations have increased our compliance and operational risk and costs;
regulatory or enforcement actions or litigation could materially adversely affect our results of operations or harm our businesses or reputation;
our businesses may be negatively affected by adverse events, publicity, government scrutiny or other reputational harm;
failure to satisfy regulatory standards, including “well capitalized” and “well managed” status or capital adequacy and liquidity rules more generally, could result in limitations on our activities and adversely affect our business and financial condition;
a failure or circumvention of our controls and procedures could have a material adverse effect on our business, reputation, results of operations and financial condition;
the application of our Title I preferred resolution strategy or resolution under the Title II orderly liquidation authority could adversely affect the Parent’s liquidity and financial condition and the Parent’s security holders;
if our resolution plan is determined not to be credible or not to facilitate an orderly resolution under the U.S. Bankruptcy Code, our business, reputation, results of operations and financial condition could be materially negatively impacted;
acts of terrorism, impacts from climate change, natural disasters, pandemics, global conflicts and
 
other geopolitical events may have a negative impact on our business and operations;
we are dependent on fee-based business for a substantial majority of our revenue and our fee-based revenues could be adversely affected by slowing in market activity, weak financial markets, underperformance and/or negative trends in savings rates or in investment preferences;
weakness and volatility in financial markets and the economy generally may materially adversely affect our business, results of operations and financial condition;
transitions away from, or changes in the calculation of, LIBOR and other benchmark rates could adversely impact our business and results of operations;
the United Kingdom’s referendum decision to leave the EU has had and may continue to have negative effects on global economic conditions, global financial markets, and our business and results of operations;
changes in interest rates and yield curves could have a material adverse effect on our profitability;
we may experience write-downs of securities that we own and other losses related to volatile and illiquid market conditions, reducing our earnings and impacting our financial condition;
our FX revenue may be adversely affected by decreases in market volatility and the cross-border investment activity of our clients;
the failure or perceived weakness of any of our significant counterparties, many of whom are major financial institutions and sovereign entities, and our assumption of credit and counterparty risk, could expose us to loss and adversely affect our business;
our business, financial condition and results of operations could be adversely affected if we do not effectively manage our liquidity;
we could incur losses if our allowance for credit losses, including loan and lending-related commitments reserves, is inadequate;
any material reduction in our credit ratings or the credit ratings of our principal bank subsidiaries, The Bank of New York Mellon or BNY Mellon, N.A., could increase the cost of funding and borrowing to us and our rated subsidiaries and have a material adverse effect on our results of operations and financial condition and on the value of the securities we issue;

2 BNY Mellon



new lines of business, new products and services or transformational or strategic project initiatives may subject us to additional risks, and the failure to implement these initiatives could affect our results of operations;
we are subject to competition in all aspects of our business, which could negatively affect our ability to maintain or increase our profitability;
our business may be adversely affected if we are unable to attract and retain employees;
our strategic transactions present risks and uncertainties and could have an adverse effect on our business, results of operations and financial condition;
tax law changes or challenges to our tax positions with respect to historical transactions may adversely affect our net income, effective tax rate and our overall results of operations and financial condition;
our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and the approval of our capital plan, applicable
 
provisions of Delaware law or our failure to pay full and timely dividends on our preferred stock;
the Parent is a non-operating holding company, and as a result, is dependent on dividends from its subsidiaries and extensions of credit from its IHC to meet its obligations, including with respect to its securities, and to provide funds for share repurchases and payment of dividends to its stockholders; and,
changes in accounting standards governing the preparation of our financial statements and future events could have a material impact on our reported financial condition, results of operations, cash flows and other financial data.

All forward-looking statements speak only as of the date on which such statements are made, and BNY Mellon undertakes no obligation to update any statement to reflect events or circumstances after the date on which such forward-looking statement is made or to reflect the occurrence of unanticipated events. The contents of BNY Mellon’s website or any other websites referenced herein are not part of this report.

BNY Mellon 3



THE BANK OF NEW YORK MELLON CORPORATION

FORM 10-K INDEX

 
 
 
 
 
 
PART I
 
 
 
 
 
 
 
 
 
 
 
PART II
 
 
 
 
 
 
 
 
 
 
 
PART III
 
 
 
 
 
 
 
 
 
 
 
PART IV
 
 
 
 
 



PART I
 


ITEM 1. BUSINESS

Description of Business

The Bank of New York Mellon Corporation, a Delaware corporation (NYSE symbol: BK), is a global company headquartered in New York, New York, with $33.1 trillion in assets under custody and/or administration and $1.7 trillion in assets under management as of Dec. 31, 2018. With its subsidiaries, BNY Mellon has been in business since 1784.

We divide our businesses into two business segments, Investment Services and Investment Management. We also have an Other segment, which includes the leasing portfolio, corporate treasury activities (including our investment securities portfolio), derivatives and other trading activity, corporate and bank-owned life insurance, renewable energy investments and business exits.

For a further discussion of BNY Mellon’s products and services, see the “Overview,” “Summary of financial highlights,” “Fee and other revenue,” “Review of businesses” and “International operations” sections in the MD&A section in the Annual Report and Notes 23 and 24 of the Notes to Consolidated Financial Statements in the Annual Report, of which portions are incorporated herein by reference. See the “Available Information” section on page 1 of this Form 10-K, which is incorporated herein by reference, for a description of how to access financial and other information regarding BNY Mellon.

Our two principal U.S. banking subsidiaries engage in trust and custody activities, investment management services, banking services and various securities-related activities. Our two principal U.S. banking subsidiaries are:

The Bank of New York Mellon, a New York state-chartered bank, which houses our Investment Services businesses, including Asset Servicing, Issuer Services, Treasury Services, Clearance and Collateral Management, as well as the bank-advised business of Asset Management; and

 
BNY Mellon, National Association (“BNY Mellon, N.A.”), a national bank, which houses our Wealth Management business.
We have four other U.S. bank and/or trust company subsidiaries concentrating on trust products and services across the United States: The Bank of New York Mellon Trust Company, National Association, BNY Mellon Trust of Delaware, BNY Mellon Investment Servicing Trust Company and BNY Mellon Trust Company of Illinois. Most of our asset management businesses, along with our Pershing businesses, are direct or indirect non-bank subsidiaries of BNY Mellon.

Each of our bank and trust company subsidiaries is subject to regulation by the applicable bank regulatory authority. The deposits of our U.S. banking subsidiaries are insured by the Federal Deposit Insurance Corporation to the extent provided by law.

BNY Mellon’s banking subsidiaries outside the United States are subject to regulation by non-U.S. regulatory authorities in addition to the Board of Governors of the Federal Reserve System (the “Federal Reserve”).  The Bank of New York Mellon SA/NV (“BNY Mellon SA/NV”) is the main banking subsidiary of The Bank of New York Mellon in continental Europe. It is authorized and regulated as a credit institution by the National Bank of Belgium and is also supervised by the European Central Bank. BNY Mellon SA/NV has its principal office in Brussels and branches in Amsterdam, the Netherlands; Dublin, Ireland; Frankfurt, Germany; London, England; the City of Luxembourg, Luxembourg; and Paris, France.  BNY Mellon SA/NV’s activities are in the Investment Services segment of BNY Mellon with a focus on global custody, asset servicing and collateral management. For additional discussion, see the “MD&A –Supervision and Regulation” section in the Annual Report.

Primary Subsidiaries

Exhibit 21.1 to this Form 10-K presents a list of BNY Mellon’s primary subsidiaries as of Dec. 31, 2018.


BNY Mellon 5



Supervision and Regulation

Information on the supervision and regulation of BNY Mellon can be found in the “MD&A – Supervision and Regulation” section in the Annual Report, which is incorporated herein by reference.

Competition

BNY Mellon is subject to competition in all aspects and areas of our business. Our Investment Services business competes with domestic and international financial services firms that offer custody services, corporate trust services, clearing services, collateral management services, credit services, securities brokerage, foreign exchange services, derivatives, depositary receipt services and cash management services and related products, as well as a wide range of technology service providers, such as financial services data processing firms. Our Investment Management business competes with domestic and international asset management firms, hedge funds, investment banking companies and other financial services companies, including trust banks, brokerage firms, and insurance companies, as well as a wide range of technology service providers. Competition is based on a number of factors including, among others, customer service, quality and range of products and services offered, technological innovation and expertise, price, reputation, rates, lending limits and customer convenience.

Many of our competitors, with the particular exception of financial holding companies, banks and trust companies, are not subject to regulation as extensive as that described under the “MD&A — Supervision and Regulation” section in the Annual Report and, as a result, may have a competitive advantage over us and our subsidiaries in certain respects.

Many broad-based financial services firms have the ability to offer a wide range of products, from loans, deposit-taking and insurance to brokerage and asset management, which may enhance their competitive position.

 
We also face intense competition in attracting and retaining qualified employees, and must compete with institutions whose compensatory arrangements are not subject to the same regulatory and supervisory frameworks that apply to us. For further discussion see “MD&A — Risk Factors – Our business may be adversely affected if we are unable to attract and retain employees” in the Annual Report, which is incorporated herein by reference.

As part of our business strategy, we seek to distinguish ourselves from competitors by the level of service we deliver to our clients. We also believe that technological innovation is an important competitive factor, and, for this reason, have made and continue to make substantial investments in this area.

The ability to maintain operations during unexpected events and to recover quickly from unexpected events is a competitive factor. We continue to evaluate and strengthen our business continuity and operational resiliency capabilities and have increased our investments in technology to steadily enhance those capabilities, including our ability to resume and sustain our operations.

For additional discussion regarding competition, see “MD&A — Risk Factors – We are subject to competition in all aspects of our business, which could negatively affect our ability to maintain or increase our profitability” in the Annual Report, which is incorporated herein by reference.

Employees

At Dec. 31, 2018, BNY Mellon and its subsidiaries had approximately 51,300 full-time employees.


6 BNY Mellon



Statistical Disclosures by Bank Holding Companies

I.
Distribution of Assets, Liabilities and Stockholders’ Equity; Interest Rates and Interest Differential

Information required by this section of Guide 3 is presented in the Annual Report in the “Net interest revenue” and “Supplemental Information (unaudited) – Rate/volume analysis” sections in the MD&A and in Note 10 of the Notes to Consolidated Financial Statements, which portions are incorporated herein by reference.

II. Securities Portfolio

A.
Book Value of Securities;
B.
Maturity Distribution and Yields of Securities; and
C.
Aggregate Book Value and Market Value of Securities Where Issuer Exceeds 10% of Stockholders’ Equity

Information required by these sections of Guide 3 is presented in the Annual Report in the “Net interest revenue” and “Consolidated balance sheet review – Securities” sections in the MD&A and in Notes 1 and 4 of the Notes to Consolidated Financial Statements, which portions are incorporated herein by reference.

III. Loan Portfolio

A.
Types of Loans; and
B.
Maturities and Sensitivities of Loans to Changes in Interest Rates

Information required by these sections of Guide 3 is presented in the Annual Report in the “Consolidated balance sheet review – Loans” section in the MD&A and Notes 1 and 5 of the Notes to Consolidated Financial Statements, which portions are incorporated herein by reference.

C.
Risk Elements; and
D.
Other Interest-bearing Assets

Information required by these sections of Guide 3 is included in the Annual Report in the “Consolidated balance sheet review – Loans” and “– Nonperforming
 
assets” and “International operations – Country risk exposure” and “– Cross-border outstandings” sections in the MD&A and Notes 1 and 5 of the Notes to Consolidated Financial Statements, which portions are incorporated herein by reference.

IV. Summary of Loan Loss Experience

Information required by this section of Guide 3 is included in the Annual Report in the “Critical accounting estimates – Allowance for loan losses and allowance for lending-related commitments” section in the MD&A, which portion is incorporated herein by reference, and below.

When losses on specific loans are identified, the portion deemed uncollectible is charged off. The allocation of the reserve for credit losses is presented in the “Consolidated balance sheet review – Asset quality and allowance for credit losses” section in the MD&A, as required by Guide 3, which is incorporated herein by reference.

Further information on our credit policies, the factors that influenced management’s judgment in determining the level of the reserve for credit exposure, and the analyses of the reserve for credit exposure are set forth in the Annual Report in the “Risk Management – Credit risk” and “Critical accounting estimates” sections in the MD&A and Notes 1 and 5 of the Notes to Consolidated Financial Statements, which portions are incorporated herein by reference.

V. Deposits

Information required by this section of Guide 3 is set forth in the Annual Report in the “Net interest revenue” and “Consolidated balance sheet review – Deposits” sections in the MD&A and in Note 8 of the Notes to Consolidated Financial Statements, which portions are incorporated herein by reference.

VI. Return on Equity and Assets

Information required by this section of Guide 3 is set forth in the Annual Report in the “Financial Summary” section, which is incorporated herein by reference.


BNY Mellon 7



VII. Short-Term Borrowings

Information required by this section of Guide 3 is set forth in the Annual Report in the “Consolidated balance sheet review – Short-term borrowings” section in the MD&A, which portion is incorporated herein by reference.

ITEM 1A. RISK FACTORS

The information required by this Item is set forth in the Annual Report under “MD&A – Risk Factors,” which portion is incorporated herein by reference.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

We believe that our owned and leased facilities are suitable and adequate for our business needs. At a number of the locations described below, we are not currently occupying all of the space under our control. Where commercially reasonable and to the extent it is not needed for future expansion, we seek to sell, lease or sublease this excess space. The following is a description of our principal properties, which are utilized by all of our business segments, as of Dec. 31, 2018:

New York area properties
We own our 23-story building located at 240 Greenwich Street in downtown Manhattan that serves as our corporate headquarters. We lease approximately 325,000 square feet of space in an office building located at 225 Liberty Street in downtown Manhattan, virtually all of which has been sublet to a third party as of Jan. 1, 2019. In addition, we lease approximately 272,000 square feet of space at 200 Park Avenue, approximately 318,000 square feet of space in Brooklyn and approximately 485,000 square feet of space in Jersey City.

Pittsburgh properties
We lease under a long-term, triple net lease the entire 54-story office building at BNY Mellon Center, 500 Grant Street. In addition, we own a 14-story office building located at 500 Ross Street.

Boston area properties
We lease approximately 226,000 square feet of space located at One Boston Place, 201 Washington Street.
 
Additionally, we lease approximately 384,000 square feet of space in Everett, Massachusetts and approximately 304,000 square feet of space in Westborough, Massachusetts.

United Kingdom properties
We have a number of leased office locations in London (including approximately 234,000 square feet of space at BNY Mellon Centre at 160-162 Queen Victoria Street and approximately 152,000 square feet of space at The Tower at One Canada Square at Canary Wharf), and leased space totaling 144,000 square feet in Manchester. We have other leased office locations throughout the United Kingdom, including locations in Poole, Leeds, Liverpool and Edinburgh.

Poland properties
We lease approximately 234,000 square feet of space in Wroclaw, Poland.

India properties
We lease approximately 828,000 square feet of space in Pune, India and approximately 827,000 square feet of space in Chennai, India.

Other properties
We also lease (and in a few instances own) office space and other facilities at numerous other locations globally, including properties located in New York, New Jersey, Connecticut, Pennsylvania, Massachusetts, Florida, Delaware, Texas, California, Illinois, Washington and Tennessee; Brussels, Belgium; Toronto, Canada; Wexford, Dublin and Cork, Ireland; Luxembourg; Frankfurt, Germany; Singapore; Hong Kong and Shanghai, China; Seoul, Korea; Tokyo, Japan; Sydney, Australia; and Rio de Janeiro, Brazil.

ITEM 3. LEGAL PROCEEDINGS

The information required by this Item is set forth in the “Legal proceedings” section in Note 21 of the Notes to Consolidated Financial Statements in the Annual Report, which portion is incorporated herein by reference.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.


8 BNY Mellon


PART II
 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock is listed on the New York Stock Exchange under the ticker symbol BK. Certain of our depositary shares, each representing 1/4,000th interest in a share of our Series C noncumulative perpetual preferred stock, are listed on the New York Stock Exchange under the ticker symbol BK PrC. Mellon Capital IV’s 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities are also listed on the New York Stock Exchange under the ticker symbol BK/P. Information relating to the closing price per share of our common stock and our common stock dividend for each full quarterly period during fiscal years 2017 and 2018 is set forth in the “Selected Quarterly Data” section in the Annual Report, which is incorporated herein by reference. As of Jan. 31, 2019, there were 27,700 holders of record of our common stock.

For additional information about dividends and a discussion of potential regulatory limitations on our receipt of funds from our regulated subsidiaries and our payment of dividends to stockholders, see the “Liquidity and dividends” and “Supervision and Regulation – Capital Planning and Stress Testing –Payment of Dividends, Stock Repurchases and Other Capital Distributions” sections in the MD&A in the Annual Report and Notes 14 and 18 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.

Additional information about our common stock, including information about share repurchases during the fourth quarter of 2018 and existing Board of Directors authorizations with respect to purchases by us of our common stock and other equity securities is provided in the “Capital – Issuer purchases of equity securities” section of the MD&A in the Annual Report and Note 14 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference. Share repurchases may be executed through open market repurchases, in privately negotiated transactions or by other means, including through repurchase plans designed to comply with Rule 10b5-1 and other derivative, accelerated share repurchase and other structured transactions.

 
ITEM 6. SELECTED FINANCIAL DATA

The information required by this Item is set forth in the “Financial Summary” section and the “Summary of financial highlights” section in the MD&A in the Annual Report and Notes 1, 2 and 3 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The information required by this Item is set forth in the MD&A and Notes 3, 11, 13, 18, 21 and 22 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information required by this Item is set forth in the “Critical accounting estimates,” “Off-balance sheet arrangements,” “Risk Management,” “Trading activities and risk management” and “Asset/liability management” sections in the MD&A in the Annual Report and “Derivative financial instruments” under Note 1 and Notes 19, 21 and 22 of the Notes to Consolidated Financial Statements in the Annual Report, which portions are incorporated herein by reference.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Reference is made to Item 15 on page 14 hereof for a detailed listing of the items under Exhibits and Financial Statements, which are incorporated herein by reference.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Not applicable.


BNY Mellon 9



ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management, including the Chief Executive Officer and Chief Financial Officer, with participation by the members of the Disclosure Committee, has responsibility for ensuring that there is an adequate and effective process for establishing, maintaining, and evaluating disclosure controls and procedures that are designed to ensure that information required to be disclosed by us in our SEC reports is timely recorded, processed, summarized and reported and that information required to be disclosed by BNY Mellon is accumulated and communicated to BNY Mellon’s management to allow timely decisions regarding the required disclosure. In addition, our ethics hotline can be used by employees and others for the anonymous communication of concerns about financial controls or reporting matters. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

As of Dec. 31, 2018, an evaluation was carried out under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and
 
procedures as defined in Exchange Act Rule 13a-15(e). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

In the ordinary course of business, we may routinely modify, upgrade or enhance our internal controls and procedures for financial reporting. There have not been any changes in our internal controls over financial reporting as defined in Rule 13a-15(f) of the Exchange Act during the fourth quarter of 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management Report on Internal Control over Financial Reporting and Report of Independent Registered Public Accounting Firm

See “Report of Management on Internal Control Over Financial Reporting” and “Report of Independent Registered Public Accounting Firm” on pages 116 and 117 of the Annual Report, each of which is incorporated herein by reference.

ITEM 9B. OTHER INFORMATION

Not applicable.


10 BNY Mellon


PART III
 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this Item is included below and in the Proxy in the following sections: “Section 16(a) Beneficial Ownership Reporting Compliance” under the heading “Additional Information - Information on Stock Ownership;” “Background” under the heading “Item 1 - Election of Directors - Resolution;” “Nominees” under the heading “Item 1 - Election of Directors;” and “Board Meetings and Committee Information - Committees and Committee Charters” and “- Audit Committee” under the heading “Item 1 - Election of Directors - Corporate Governance and Board Information,” which are incorporated herein by reference.
CODE OF ETHICS

We have adopted a code of ethics for our employees which we refer to as our Code of Conduct. The Code of Conduct applies to all employees of BNY Mellon or an entity that is more than 50% owned by us, including our Chief Executive Officer (principal executive officer), Chief Financial Officer (principal financial officer) and Controller (principal accounting officer). The Code of Conduct is posted on our
 
website at www.bnymellon.com/ethics/codeofconduct.pdf. We also have a code of ethics for our directors, which we refer to as our Directors’ Code of Conduct. The Directors’ Code of Conduct applies to all directors of BNY Mellon. The Directors’ Code of Conduct is posted on our website at www.bnymellon.com/governance/directorscodeofconduct.pdf. We intend to disclose on our website any amendments to or waivers of the Code of Conduct relating to executive officers (including the officers specified above) and will disclose any amendments to or waivers of the Directors’ Code of Conduct relating to our directors.

EXECUTIVE OFFICERS OF THE REGISTRANT

The positions of Chairman of the Board, Chief Executive Officer and President are each held for the year for which the Board of Directors was elected and until the appointment and qualification of a successor or until earlier death, resignation, disqualification or removal. All other executive officers serve at the pleasure of the appointing authority. No executive officer has a family relationship to any other executive officer or director or nominee for director.

Name
Age
Positions and offices
 
 
 
Bridget E. Engle
55
Ms. Engle has served as Senior Executive Vice President and Chief Information Officer of BNY Mellon since June 2017. From April 2015 to March 2017, Ms. Engle served as Bank of America Corporation’s Chief Information Officer for Global Commercial Banking and Markets Technology. From 2011 to April 2015, Ms. Engle was Bank of America’s Chief Information Officer for Consumer Banking.


 
 
 
 
 
Thomas P. (Todd) Gibbons
62
Mr. Gibbons has served as Vice Chairman and Chief Executive Officer of Clearing, Markets and Client Management of BNY Mellon since January 2018 and was Vice Chairman and Chief Financial Officer of BNY Mellon from July 2008 to January 2018.

 
 
 
 
 
Mitchell E. Harris
64
Mr. Harris has served as Senior Executive Vice President and Chief Executive Officer of Investment Management of BNY Mellon since February 2016 and was President of Investment Management from May 2011 to February 2016.

 
 
 
 
 
Monique R. Herena
48
Ms. Herena has served as Senior Executive Vice President and Chief Human Resources Officer of BNY Mellon since April 2014. From 2013 to April 2014, Ms. Herena served as Senior Vice President Human Resources and Chief Human Resources Officer Global Groups, Functions and Corporate for PepsiCo Inc.

 
 
 
 
 
Hani A. Kablawi
50
Mr. Kablawi has served as Senior Executive Vice President and Chairman of EMEA and Chief Executive Officer of Global Asset Servicing of BNY Mellon since January 2018 and was Chief Executive Officer of EMEA Investment Services from July 2016 to January 2018. Mr. Kablawi previously served as Chief Executive Officer of EMEA Asset Servicing from January 2012 to July 2016.

 
 
 
 
 

BNY Mellon 11



Name
Age
Positions and offices
45
Mr. Kurimsky has served as Vice President and Controller of BNY Mellon since July 2015 and was Acting Controller from February 2015 to July 2015. Mr. Kurimsky previously served as Deputy Controller of BNY Mellon from May 2014 to February 2015. From October 2006 to April 2014, Mr. Kurimsky served as a partner in the Financial Services Practice at KPMG LLP.

 
 
 
 
 
Francis (Frank) La Salla
55
Mr. La Salla has served as Senior Executive Vice President and Chief Executive Officer of Issuer Services of BNY Mellon since January 2018 and was Chief Executive Officer of Corporate Trust from May 2017 to January 2018. Mr. La Salla previously served as Chief Executive Officer of Global Structured Products and Alternative Investment Services from March 2014 to May 2017. From May 2003 to March 2014, Mr. La Salla was Managing Director at Pershing LLC, a wholly-owned subsidiary of BNY Mellon, where he was Co-Head of Global Client Relationships and Head of Trading Services.

 
 
 
 
 
54
Mr. McCarthy has served as Senior Executive Vice President and General Counsel of BNY Mellon since April 2014 and was Senior Deputy General Counsel, with oversight of the legal teams supporting BNY Mellon’s Litigation, Enforcement, Employment Law, Asset Servicing and corporate center functions, from August 2013 to April 2014. From September 2010 to August 2013, Mr. McCarthy served as Deputy General Counsel for the Litigation, Enforcement and Employment Law functions at BNY Mellon.

 
 
 
 
 
Lester J. Owens
61
Mr. Owens has served as Senior Executive Vice President and Head of Operations of BNY Mellon since February 2019. From 2007 to December 2018, Mr. Owens served as managing director responsible for Wholesale Banking Operations at JPMorgan Chase & Co., with additional responsibility for Corporate & Investment Bank Client Onboarding from 2017 through 2018.
 
 
 
 
 
Roman Regelman
47
Mr. Regelman has served as Senior Executive Vice President and Head of Digital of BNY Mellon since September 2018. From 2011 to August 2018, Mr. Regelman was partner, managing director and co-leader of the financial institutions digital business at Boston Consulting Group.
 
 
 
 
 
43
Mr. Santomassimo has served as Senior Executive Vice President and Chief Financial Officer of BNY Mellon since January 2018 and was Chief Financial Officer of Investment Services from July 2016 to January 2018. Mr. Santomassimo served as Chief Financial Officer, Banking, at JPMorgan Chase & Co., which included Investment Banking (Advisory and Equity and Debt Capital Markets) as well as Treasury Services from December 2013 to June 2016 and Chief Financial Officer, Technology & Operations, for the same division at JPMorgan Chase & Co. from December 2012 to December 2013.

 
 
 
 
 
53
Mr. Scharf has served as a director and Chief Executive Officer of BNY Mellon since July 2017. In January 2018, Mr. Scharf became Chairman of BNY Mellon. From October 2012 through December 2016, Mr. Scharf served as director and Chief Executive Officer of Visa Inc.


 
 
 
 
 
Akash Shah
33
Mr. Shah has served as Senior Executive Vice President and Head of Strategy of BNY Mellon since July 2018. From 2006 to July 2018, Mr. Shah worked at McKinsey & Company, mostly recently as a partner and co-head the Capital Markets & Investment Banking practice.
 
 
 
 
 
James S. Wiener
51
Mr. Wiener has served as Senior Executive Vice President and Chief Risk Officer of BNY Mellon since November 2014. Mr. Wiener served as a senior partner at Oliver Wyman Group from 2003 to November 2014.

 
 
 
 
 




12 BNY Mellon



ITEM 11. EXECUTIVE COMPENSATION

The information required by this Item is included in the Proxy in the following sections: “Director Compensation” under the heading “Item 1 - Election of Directors;” “Compensation Discussion and Analysis” and “Executive Compensation Tables and Other Compensation Disclosure” under the heading “Item 2 - Advisory Vote on Compensation;” “Board Meetings and Committee Information - Committees and Committee Charters” and “- Human Resources and Compensation Committee” under the heading “Item 1 - Election of Directors - Corporate Governance and Board Information,” which are incorporated herein by reference. The information incorporated herein by reference to the section “Report of the HRC Committee” under the heading “Item 2 - Advisory Vote on Compensation - Compensation Discussion and Analysis” is deemed furnished hereunder.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this Item is included in the Proxy in the following sections: “Equity Compensation Plans” and “Information on Stock Ownership” under the heading “Additional Information,” which are incorporated herein by reference.


 
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this Item is included in the Proxy in the following sections: “Business Relationships and Related Party Transactions Policy” under the heading “Additional Information - Other Information;” “Director Independence” under the heading “Item 1 - Election of Directors - Corporate Governance and Board Information;” and “Board Meetings and Committee Information - Committees and Committee Charters,” “- Audit Committee,” “- Corporate Governance, Nominating and Social Responsibility Committee” and “- Human Resources and Compensation Committee” under the heading “Item 1 - Election of Directors - Corporate Governance and Board Information,” which are incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The information required by this Item is included in the Proxy in the following section: “Item 3 – Ratification of KPMG LLP,” which is incorporated herein by reference.


BNY Mellon 13


PART IV
 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)
The financial statements, schedules and exhibits required for this Form 10-K are incorporated by reference as indicated in the following index. Page numbers refer to pages of the Annual Report for Items (1) and (2) Financial Statements and Schedules.

(1)(2)
Financial Statements and Schedules
Page No.
 
 
 
 
Consolidated Income Statement
119-120
 
Consolidated Comprehensive Income Statement
121
 
Consolidated Balance Sheet
122
 
Consolidated Statement of Cash Flows
123
 
Consolidated Statement of Changes in Equity
124-125
 
Notes to Consolidated Financial Statements
126-198
 
Report of Independent Registered Public Accounting Firm
199
 
 
 
 
Selected Quarterly Data (unaudited)
108
 
 
 
(3)
Exhibits
 
 
See (b) below.
 


(b)
The exhibits listed on the Index to Exhibits on pages 15 through 22 hereof are incorporated by reference or filed or furnished herewith in response to this Item.


(c)
Other Financial Data

None.

ITEM 16. FORM 10-K SUMMARY

None.


14 BNY Mellon



Pursuant to the rules and regulations of the SEC, BNY Mellon has filed certain agreements as exhibits to this Form 10-K. These agreements may contain representations and warranties by the parties to such agreements. These representations and warranties have been made solely for the benefit of the other party or parties to such agreements and (i) may have been qualified by disclosures made to such other party or parties, (ii) were made only as of the date of such agreements or such other date(s) as may be specified in such agreements and are subject to more recent developments, which may not be fully reflected in BNY Mellon’s public disclosure, (iii) may reflect the allocation of risk among the parties to such agreements and (iv) may apply materiality standards that are different from what may be viewed as material to investors. Accordingly, these representations and warranties may not describe BNY Mellon’s actual state of affairs at the date hereof and should not be relied upon.

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
3.1
 
Restated Certificate of Incorporation of The Bank of New York Mellon Corporation.



 

3.2
 
Certificate of Designations of The Bank of New York Mellon Corporation with respect to Series A Noncumulative Preferred Stock, dated June 15, 2007.

 

3.3
 
Certificate of Designations of The Bank of New York Mellon Corporation with respect to Series C Noncumulative Perpetual Preferred Stock, dated Sept. 13, 2012.
 

3.4
 
Certificate of Designations of The Bank of New York Mellon Corporation with respect to Series D Noncumulative Perpetual Preferred Stock, dated May 16, 2013.
 
3.5
 
Certificate of Designations of The Bank of New York Mellon Corporation with respect to Series E Noncumulative Perpetual Preferred Stock, dated April 27, 2015.
 
3.6
 
Certificate of Designations of The Bank of New York Mellon Corporation with respect to Series F Noncumulative Perpetual Preferred Stock, dated July 29, 2016.
 
3.7
 
Amended and Restated By-Laws of The Bank of New York Mellon Corporation, as amended and restated on July 10, 2007 and subsequently amended on April 14, 2009, Aug. 11, 2009, Feb. 9, 2010, July 2, 2010, Oct. 12, 2010, Oct. 8, 2013, March 5, 2015, Oct. 13, 2015 and Feb. 12, 2018.

 

BNY Mellon 15


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
4.1
 
 
None of the instruments defining the rights of holders of long-term debt of the Parent or any of its subsidiaries represented long-term debt in excess of 10% of the total assets of the Company as of Dec. 31, 2018. The Company hereby agrees to furnish to the Commission, upon request, a copy of any such instrument.
 
N/A
10.1
*
The Bank of New York Company, Inc. Excess Contribution Plan as amended through July 10, 1990.
 
Previously filed as Exhibit 10(b) to The Bank of New York Company, Inc.’s Annual Report on Form 10-K (File No. 001-06152) for the year ended Dec. 31, 1990, and incorporated herein by reference.

10.2
*
Amendments dated Feb. 23, 1994 and Nov. 9, 1993 to The Bank of New York Company, Inc. Excess Contribution Plan.
 

10.3
*
Amendment to The Bank of New York Company, Inc. Excess Contribution Plan dated as of Nov. 1, 1995.
 
10.4
*
Amendment to The Bank of New York Company, Inc. Excess Contribution Plan dated as of Nov. 12, 2002.
 
10.5
*
Amendment to The Bank of New York Company, Inc. Excess Contribution Plan dated as of Oct. 9, 2006.

 
10.6
*
The Bank of New York Company, Inc. Excess Benefit Plan as amended through Dec. 8, 1992.
 
Previously filed as Exhibit 10(d) to The Bank of New York Company, Inc.’s Annual Report on Form 10-K (File No. 001-06152) for the year ended Dec. 31, 1992, and incorporated herein by reference.
10.7
*
Amendment dated as of Aug. 11, 1994 to The Bank of New York Company, Inc. Excess Benefit Plan.
 
10.8
*
Amendment dated as of Nov. 1, 1995 to The Bank of New York Company, Inc. Excess Benefit Plan.
 

16 BNY Mellon


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
10.9
*
Amendment dated as of July 1, 1996 to The Bank of New York Company, Inc. Excess Benefit Plan.
 
10.10
*
The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
Previously filed as Exhibit 10(n) to The Bank of New York Company, Inc.’s Annual Report on Form 10-K (File No. 001-06152) for the year ended Dec. 31, 1992, and incorporated herein by reference.
10.11
*
Amendment dated as of March 9, 1993 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
10.12
*
Amendment dated as of Oct. 11, 1994 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
10.13
*
Amendment dated as of July 1, 1996 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
10.14
*
Amendment dated as of Nov. 12, 1996 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
10.15
*
Amendment dated as of July 11, 2000 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
10.16
*
Amendment dated as of Feb. 13, 2001 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 
10.17
*
Amendment dated as of Jan. 1, 2006 to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan.
 

BNY Mellon 17


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
10.18
*
Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.
 
10.19
*
Amendment dated as of Nov. 8, 1994 to Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.
 
10.20
*
Amendment dated Feb. 11, 1997 to Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.
 
10.21
*
Amendment to Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc. dated as of July 11, 2000.
 
10.22
*
Amendment dated as of Nov. 12, 2002 to Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.
 
10.23
*
Mellon Financial Corporation Director Equity Plan (2006).
 

10.24
*
The Bank of New York Mellon Corporation Deferred Compensation Plan for Directors, effective Jan. 1, 2008.
 
10.25
 
 
Lease dated as of Dec. 29, 2004, between 500 Grant Street Associates Limited Partnership and The Bank of New York Mellon with respect to BNY Mellon Center.
 

10.26
*
The Bank of New York Mellon Corporation Deferred Compensation Plan for Employees.
 
10.27
*
Form of Long Term Incentive Plan Deferred Stock Unit Agreement for Directors of The Bank of New York Corporation.

 


18 BNY Mellon


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
10.28
*
Amendment to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan, dated as of Jan. 1, 2009.
 
10.29
*
Amendment to The Bank of New York Company, Inc. Excess Benefit Plan, dated as of Jan. 1, 2009.
 
10.30
*
Amendment to The Bank of New York Company, Inc. Excess Contribution Plan, dated as of Jan. 1, 2009.
 
10.31
*
The Bank of New York Mellon Corporation Policy Regarding Shareholder Approval of Future Senior Officers Severance Arrangements, adopted July 12, 2010.

 

10.32
*
2011 Form of Executive Stock Option Agreement.
 

10.33
*
The Bank of New York Mellon Corporation Long-Term Incentive Plan.
 

10.34
*
Amended and Restated Long-Term Incentive Plan of The Bank of New York Mellon Corporation.
 
10.35
*
2012 Form of Nonstatutory Stock Option Agreement.

 
10.36
*
The Bank of New York Mellon Corporation Defined Contribution IRC 401(a)(17) Plan.

 
10.37
 
Lease agreement by and between The Bank of New York Mellon and WFP Tower Co. L.P., dated June 25, 2014.
 

BNY Mellon 19


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
10.38
*
Amendment to The Bank of New York Company, Inc. Supplemental Executive Retirement Plan, dated as of Dec. 31, 2014.

 
10.39
*
2015 Form of Performance Share Unit Agreement.
 
10.40
*
2015 Form of Restricted Stock Unit Agreement.
 
10.41
*
The Bank of New York Mellon Corporation Defined Contribution IRC 401(a)(17) Plan (as amended and restated).
 
10.42
*
Amendment dated as of Dec. 14, 2015 to The Bank of New York Company, Inc. Excess Benefit Plan.

 
10.43
*
The Bank of New York Mellon Corporation Executive Severance Plan (as amended effective Feb. 19, 2016).
 

10.44
*
The Bank of New York Mellon Corporation 2016 Executive Incentive Compensation Plan.
 
10.45
*
Form of Amended and Restated Indemnification Agreement with Directors of The Bank of New York Mellon Corporation.
 
10.46
*
Form of Amended and Restated Indemnification Agreement with Executive Officers of The Bank of New York Mellon Corporation.
 
10.47
*
The Bank of New York Mellon Corporation Executive Severance Plan, as amended.
 
10.48
*
2016 Form of Restricted Stock Unit Agreement.
 

20 BNY Mellon


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
10.49
*
2016 Form of Performance Share Unit Agreement.
 
10.50
*
Letter Agreement, dated July 13, 2017, between The Bank of New York Mellon Corporation and Charles W. Scharf.
 
10.51
*
2017 Form of Performance Share Unit Agreement.
 
10.52
*
2017 Form of Restricted Stock Unit Agreement.
 
10.53
*
The Bank of New York Mellon Corporation Executive Severance Plan, as amended on Feb. 12, 2018.
 
10.54
*
2018 Form of Performance Share Unit Agreement
 
10.55
*
2018 Form of Restricted Stock Unit Agreement
 
10.56
*
Amendment dated as of Oct. 18, 2018 to The Bank of New York Company, Inc. Excess Benefit Plan
 
13.1
 
 
All portions of The Bank of New York Mellon Corporation 2018 Annual Report to Shareholders that are incorporated herein by reference. The remaining portions are furnished for the information of the SEC and are not “filed” as part of this filing.

 
21.1
 
 
 

23.1
 
 
Consent of KPMG LLP.
 

24.1
 
 
 


BNY Mellon 21


INDEX TO EXHIBITS (continued)
 

Exhibit
 
Description
 
Method of Filing
 
 
 
 
 
 
31.1
 
 
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 
31.2
 
 
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1
 
 
Certification of the Chief Executive Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
32.2
 
 
Certification of the Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
101.INS
 
XBRL Instance Document.
 
101.SCH
 
XBRL Taxonomy Extension Schema Document.

 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.

 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.

 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document.

 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.
 
* Management contract or compensatory plan arrangement.


22 BNY Mellon



SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, BNY Mellon has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
The Bank of New York Mellon Corporation
 
 
 
 
By:
 
 
 
 
Chairman and Chief Executive Officer
 
 
 
 
 


Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of BNY Mellon and in the capacities and on the date indicated.

 
Signature
 
 
Capacities
 
 
 
 
 
By:
 
 
Director and Principal Executive Officer
 
 
 
 
 
Chairman and Chief Executive Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
Principal Financial Officer
 
 
 
 
 
Chief Financial Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
Principal Accounting Officer
 
 
 
 
 
Corporate Controller
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Steven D. Black; Linda Z. Cook; Joseph J. Echevarria; Edward P. Garden; Jeffrey A. Goldstein; John M. Hinshaw; Edmund F. Kelly; Jennifer B. Morgan; Mark A. Nordenberg; Elizabeth E. Robinson; Samuel C. Scott III
 
 
Directors
 
 
 
 
 
 
 
 
 
 
By:
 
 
 
 
 
 
 
Attorney-in-fact
 
 
 

BNY Mellon 23


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/27/19
1/31/19
1/1/19
For Period end:12/31/1811-K,  13F-HR
10/18/188-K
6/30/1810-Q,  13F-HR,  13F-HR/A
2/12/188-K,  SC 13G/A
7/13/178-K
7/29/168-K
2/19/164,  8-K
12/14/15
10/13/158-K,  SC 13G
4/27/153/A,  4
3/5/158-K
12/31/1410-K,  11-K,  13F-HR,  13F-HR/A,  5,  8-K,  ARS
6/25/148-K
10/8/138-K
5/16/138-K
9/13/12FWP
10/12/103,  8-K
7/12/10
7/2/10
2/9/104,  8-K,  SC 13G/A
8/11/094,  8-K
4/14/098-K,  DEF 14A,  PRE 14A
1/1/09
1/1/08
7/10/07424B2
6/15/07
10/9/06
1/1/06
12/29/04
11/12/02
2/13/01
7/11/00
2/11/97
11/12/96
7/1/96
11/1/95
11/8/94
10/11/94
8/11/94
2/23/94
11/9/93
3/9/93
12/31/92
12/8/92
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/03/19  SEC                               UPLOAD7/08/19    2:131K Bank of New York Mellon Corp.
 5/06/19  SEC                               UPLOAD7/08/19    2:240K Bank of New York Mellon Corp.
Top
Filing Submission 0001390777-19-000050   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 10:21:33.2am ET